Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc > Record Second Quarter 2021 Results and Provides an Update
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by annoncpleon Aug 12, 2021 11:30am
197 Views
Post# 33691682

RE:RE:RE:RE:RE:Record Second Quarter 2021 Results and Provides an Update

RE:RE:RE:RE:RE:Record Second Quarter 2021 Results and Provides an Updateso at first glance how does this compare to spartan velvet aquisition, or even to spartan stock price to pipe stock price, which has better value at this point? im in both and not really seeing clear direction
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities